Higher fasting blood glucose was associated with worse in-hospital clinical outcomes in patients with primary intracerebral hemorrhage: From a large-scale nationwide longitudinal registry

CNS Neurosci Ther. 2022 Dec;28(12):2260-2267. doi: 10.1111/cns.13972. Epub 2022 Sep 24.

Abstract

Introduction: Studies that investigated the relationship between fasting blood glucose (FBG) and intracerebral hemorrhage (ICH) outcomes were insufficient.

Aim: We aimed to investigate the association between FBG level and in-hospital clinical outcomes in patients with primary ICH.

Results: A total of 34,507 patients were enrolled in the final study. Compared with the reference group, the ≥6.1 and <7 mmol/L group showed nonsignificant higher in-hospital mortality (adjusted odds ratio [OR] 1.20, 95% confidence interval [CI] 0.69-2.11, p = 0.52), and a significant higher proportion of intracranial hematoma evacuation (adjusted OR 1.56, 95% CI 1.26-1.92, p < 0.001). The ≥7 mmol/L group showed both significant higher in-hospital mortality (adjusted OR 2.08, 95% CI 1.42-3.04, p = 0.52) and a significant higher proportion of intracranial hematoma evacuation (adjusted OR 2.09, 95% CI 1.78-2.47, p < 0.001).

Conclusion: Higher FBG level was correlated with both higher mortality and proportion of evacuation of intracranial hematoma.

Keywords: cerebral hemorrhage; glucose; mortality; outcome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Glucose*
  • Cerebral Hemorrhage
  • Fasting*
  • Hematoma
  • Hospitals
  • Humans
  • Registries

Substances

  • Blood Glucose